Sara Nayeem

Sara Nayeem, a venture investor with ~16 years focused on therapeutics and rare disease, describes career turns from medicine to early-stage biotech investing. She talks about firm styles and timing for investments. Topics include rare disease evolution, regulatory and clinical trial challenges, accelerator models, and how Innovate/Ennovate approaches larger first checks into therapeutics.